Blockchain Registration Transaction Record

Alcanza Acquires Tampa Bay Medical Research in Major Clinical Trial Expansion

Alcanza Clinical Research acquires Tampa Bay Medical Research, expanding clinical trial access. Dr. Sureka Bollepalli joins Alcanza's network of 25+ research facilities nationwide.

This acquisition matters because it represents a significant consolidation in the clinical research industry that directly impacts patient access to cutting-edge medical treatments. As pharmaceutical companies increasingly rely on clinical trial networks to test new therapies, mergers like this one create larger, more efficient organizations that can accelerate research timelines and bring treatments to market faster. For patients in the Tampa Bay region and beyond, this means greater access to potentially life-saving clinical trials, particularly for those from underrepresented communities who have historically faced barriers to participation. The integration of TBMR's nearly four decades of local expertise with Alcanza's national infrastructure creates a powerful combination that could improve clinical trial diversity and outcomes while maintaining the personalized care that patients value. In an era where medical innovation depends heavily on robust clinical research, this strategic move strengthens the pipeline for new treatments across numerous therapeutic areas.